![](/img/cover-not-exists.png)
Immunomodulators, sFas and Fas-L as potential noninvasive predictors of IFN treatment in patients with HCV genotype-4
A. R. N. Zekri, H. A. Haleem, G. E. -D. Esmat, A. A. Bahnassy, H. M. A. El-Din, M. M. Hafez, A. F. Sharaby, H. Sharaf, M. S. E.-D. ZakariaVolume:
14
Year:
2007
Language:
english
Pages:
10
DOI:
10.1111/j.1365-2893.2006.00832.x
File:
PDF, 515 KB
english, 2007